Abstract
This study assessed psychological adjustment and quality of life relative to population-based norms and knowledge about hereditary hemochromatosis in a sample of 101 patients who attended a hemochromatosis clinic. Participants were assessed prior to their clinic visit, and two weeks and 12 months after attendance, using self-administered questionnaires. Mean Mental Health Component Scores from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) (45.3, 95% CI 43.2, 47.4) were as compromised as those found amongst stroke victims (45.9, 95% CI 42.8, 49.0) who had participated in a national health survey. Recall of the genetic testing result was less than optimal, in that only 69.3% of those with genetic testing results knew whether they carried one or two mutations. This study demonstrates that patients would benefit from routine assessment of psychological distress and referral to mental health professionals of those whose levels of distress suggest a need for clinical intervention. Results also show that patients may benefit from strategies aimed at improving recall of genetic testing results.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adams, P. C. (1995). Screening blood donors for hereditary hemochromatosis: Decision analysis model based o a 30-year database. Gastroenterol, 109, 177–188.
Adams, P. C., & Speechley, M. (1996). The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol, 123, 707–710.
Allen, K., & Williamson, R. (1999). Should we genetically test everyone for haemochromatosis? J Med Ethics, 25, 209–214.
Australian Bureau of Statistics. (1997). National Health Survey: SF-36 Population Norms. ABS Catalogue No. 4399.0: Canberra.
Axworthy, D., Brock, D. J. H., Bobroww, M., & Marteau, T. M. (1996). Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. Lancet, 347, 1443–1446.
Bassett, M., Dunn, C., Battese, K., & Peek, K. (2001). Acceptance of neonatal genetic screening for hereditary hemochromatosis by informed parents. Genet Test, 5, 317–320.
Bekker, H., Denniss, G., Modell, M., Bobrow, M., & Marteau, T. (1994). The impact of population based screening for carriers of cystic fibrosis. J Med Genet, 31, 364–368.
Beutler, E., Felliti, V., Kaziol, J., Ho, N., & Gelbart, T. (2002). Penetrance of 845GA (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet, 359, 211–218.
Bomford, A. (2002). Genetics of haemochromatosis. Lancet, 360, 1673–1681.
Burke, W., Press, N., & McDonnell, S. M. (1998a). Hemochromatosis: Genetics helps to define a multifactorial disease. Clin Genet, 54, 44–52.
Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., et al. (1998b). Hereditary hemochromatosis: Gene discovery and its implications for population-based screening. JAMA, 280, 172–178.
Cella, D. F., Mahon, S. M., & Donovan, M. I. (1990). Cancer recurrence as a traumatic event. Behav Med, 16, 15–22.
Cogswell, M., Burke, W., McDonnell, S., & Franks, A. (1999). Screening for hemochromatosis: A public health perspective. Am J Prev Med.
Collins, V., Meiser, B., Halliday, J., Gaff, C., & St John, J. (Submitted to Cancer on 10/7/2004.). Screening and preventive behaviour one year following predictive genetic testing for hereditary non-polyposis colorectal cancer.
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet, 13, 399–408.
Gertig, D., Fletcher, A., & Hopper, J. (2002). Public health aspects of genetic screening for hereditary hemochromatosis in Australia. Austr NZ J Pub Health, 26, 518–524.
Hicken, B., Calhoun, D., & Tucker, D. (2003). Genetic testing for haemochromatosis: Attitudes and acceptability among young and older adults. Genet Test, 7, 235–239.
Hicken, B. L., Calhoun, D. A., Barton, J. C., & Tucker, D. C. (2004). Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis. Genet Test, 8, 90–7.
Hornsby, J., Sappington, J., Mongan, P., Gullen, W., Bono, S., & Altekruse, E. (1985). Risk for Bladder Cancer. JAMA, 253, 1899–1902.
Jarvinen, H. J., Aarnio, M., Mustonen, H. et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterol, 188, 829–834.
Jazwinska, E. C., Cullen, L. M., & Busfield, F.E.A. (1996). Haemochromatosis and HLA-H. Nat Genet, 13, 399–408.
Kerlikowske, K., Grady, D., Barclay, J., Sickles, E. A., Eaton, A., & Ernster, V. (1996). Effect of age, breast density and family history on the sensitivity of first screening mammography. JAMA, 276, 33–38.
Leggett, B. (1996). Iron in an Australian population. J Gastroenterol Hepatol, 11, 1037–1039.
Lerman, C., Hughes, C., Croyle, R., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med, 31, 75–80.
Lipkus, I. M., & Hollands, J. G. (1999). The visual communication of risk. Journal of the National Cancer Institute Monographs, 25, 149–163.
Lobb, E., Butow, P., Meiser, B., Barratt, A., Gaff, C., Young, M., et al. (2004). Communication and information-giving in high-risk breast cancer consultations: Influence on patient outcomes. British Journal of Cancer 2004;90(2):321–327., 90, 321–327.
Lobb, E., Butow, P., Meiser, B., Barratt, A., Tucker, K., Gaff, C., et al. (2002). Tailoring communication in consultations with women from high-risk breast cancer families. Br J Cancer, 87, 502–508.
Marteau, T. M., & Bekker, H. (1992). The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol, 31, 301–306.
McCaul, K. D., Branstetter, A. D., O'Donnell, S. M., Jacobson, K., & Quinlan, K. B. (1998). A descriptive study of breast cancer worry. J Behav Med, 21, 565–579.
McHorney, C. A., Ware, J. E., Lu, C. F. R., & Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care, 32, 40–66.
McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care, 31, 247–263.
McLaren, C., Barton, J., Adams, P., Harris, E., Acton, R., Press, N., et al. (2003). Haemochromatosis and Iron Overload Screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults. Am J Med Sc, 325, 53–62.
Meiser, B., Butow, P., Price, M., Bennett, B., Berry, G., Tucker, K., et al. (2003). Attitudes to prophylactic strategies in Australian women at increased risk for breast cancer. J Women Health, 12, 769–778.
Michie, S., French, D., & Marteau, T. (2002). Predictive genetic testing: Mediators and moderators on anxiety. Inter J Behav Med, 9, 309–321.
Nisselle, A., Delatyki, M., Collins, V., Metcalfe, S., Aitken, M., du Sart, D., et al. (2004). Implementation of HaemScreen, a workplace-based genetic screening program for haemochromatosis. Clin Genet, 5, 358–367.
Olynyk, J., Cullen, D., Aquilia, S., Rossi, E., Summerville, L., & Powell, L. (1999). A population-based study of the clinical expression of the hemochromatosis gene. New Engl J Med, 341, 718–724.
Powell, L. (2002). Hereditary hemochromatosis and iron overload diseases. J Gastroenterol Hepatol, 17 (Suppl.), 191–195.
Power, T., & Adams, P. (2001). Psychosocial impact of C282Y mutation testing for haemochromatosis. Genet Test, 5, 107–110.
Spielberger, C. D. (1983). State-Trait Anxiety Inventory for Adults (Form Y). Mind Garden: Palo Alto.
Thewes, B., Meiser, B., & Hickie, I. (2001). Validation of the Impact of Events Scale in women at increased risk of developing hereditary breast cancer. Psycho-Oncol, 10, 459–468.
Ware, J., & Kosinski, M. (2001). SF-36 Physical and Mental Health Summary Scales: A manual for users of version 1. Quality Metric Inc.: Lincoln, RI.
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual Framework and item selection. Med Care, 30, 473–483.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meiser, B., Dunn, S., Dixon, J. et al. Psychological Adjustment and Knowledge About Hereditary Hemochromatosis in a Clinic-Based Sample: A Prospective Study. J Genet Counsel 14, 453–463 (2005). https://doi.org/10.1007/s10897-005-6192-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-005-6192-y